GS-100 — catalyst calendar
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2027-03 (month) in 4mo
ESTIMATED |
READOUT
Safety and Efficacy of GS-100 Gene Therapy in Patients With NGLY1 Deficiency
Phase 3 · NGLY1 Deficiency |
Grace Science, LLC | GS-100 |
ClinicalTrials.gov ↗
✓ Source-checked 2026-11-02
Sponsor-projected date — can change
|